What is an appropriate management plan and ICD‑10‑CM codes for a SOAP note for a patient with small urticaria without edema on the posterior ears, neck, and left side of the face, and a few buttock bumps, who denies shortness of breath and chest pain?

Management Plan for Acute Urticaria

Start with a non-sedating second-generation H1-antihistamine (cetirizine 10 mg, loratadine 10 mg, or fexofenadine 180 mg once daily) as first-line therapy, which is the cornerstone of urticaria management and effective in most cases of acute urticaria. 1

Immediate Assessment

• Rule out anaphylaxis: Confirm absence of respiratory compromise, hypotension, or systemic symptoms beyond the skin findings (patient denies SOB/CP—good prognostic sign)
• Identify triggers: Question about recent medication use (especially NSAIDs, aspirin, ACE inhibitors, antibiotics), new foods, infections, or physical triggers
• Examine lesions: Confirm wheals are transient (lasting <24 hours), migratory, and blanch with pressure—this distinguishes urticaria from urticarial vasculitis

Pharmacologic Management

First-Line Treatment

Prescribe one of the following non-sedating H1-antihistamines 1:

• Cetirizine 10 mg once daily (fastest onset—reaches maximum concentration quickest)
• Loratadine 10 mg once daily
• Fexofenadine 180 mg once daily
• Levocetirizine 5 mg once daily

Offer the patient a choice between at least two different antihistamines, as individual responses vary significantly. 1

If Inadequate Response After 2-4 Days

• Increase the antihistamine dose up to 4 times the standard dose (e.g., cetirizine 40 mg daily, loratadine 40 mg daily) 1, 2
• This updosing is safe, commonly practiced, and more effective than adding other medications

Adjunctive Measures

• Apply cooling antipruritic lotions (calamine or 1% menthol in aqueous cream) for symptomatic relief 1
• Consider adding a sedating antihistamine at bedtime (hydroxyzine 10-50 mg or chlorphenamine 4-12 mg) only if sleep is significantly disrupted, though this adds little therapeutic benefit if H1 receptors are already saturated 1

Corticosteroids: Use Sparingly

Short-course oral corticosteroids (prednisone 40-50 mg daily for 3 days) may be considered for severe acute urticaria, though recent evidence shows limited added benefit over antihistamines alone. 3 Two out of three RCTs found no improvement when adding corticosteroids to antihistamines for acute urticaria. Reserve steroids for truly severe cases with significant angioedema or when rapid control is essential.

Trigger Avoidance

Counsel the patient to avoid the following aggravating factors 1:

• NSAIDs and aspirin (can worsen urticaria in up to 30% of patients)
• Alcohol
• Overheating (hot showers, excessive exercise)
• Tight clothing or pressure on affected areas
• Stress (acknowledge but don't overemphasize)

Patient Education

• Explain that acute urticaria typically resolves within days to weeks, with excellent prognosis 1
• Clarify that a specific cause is often not identified (60-80% of cases are idiopathic), but this doesn't affect treatment success
• Reassure that the absence of respiratory symptoms and angioedema indicates low risk of progression to anaphylaxis
• Provide written information about urticaria management

Follow-Up

• Reassess in 1-2 weeks if symptoms persist
• If urticaria continues beyond 6 weeks, reclassify as chronic spontaneous urticaria and consider:
  • Basic laboratory tests (CBC, CRP/ESR) only if symptoms suggest systemic disease 4
  • Referral to dermatology or allergy if refractory to updosed antihistamines

Red Flags Requiring Urgent Evaluation

• Development of respiratory distress, stridor, or wheezing
• Hypotension or dizziness
• Individual wheals lasting >24 hours (suggests urticarial vasculitis)
• Painful rather than pruritic lesions
• Systemic symptoms (fever, joint pain, malaise)

---

ICD-10-CM Codes

Primary Diagnosis:

• L50.9 - Urticaria, unspecified (use if no specific trigger identified)
• L50.0 - Allergic urticaria (use only if clear allergic trigger identified)
• L50.1 - Idiopathic urticaria (appropriate if no cause found after evaluation)

Additional Codes if Applicable:

• L50.3 - Dermatographic urticaria (if physical urticaria suspected on buttocks from pressure/friction)
• R21 - Rash and other nonspecific skin eruption (can be used as secondary code for the buttock lesions if character differs from facial urticaria)

Most appropriate for this presentation: L50.9 (Urticaria, unspecified) as the primary code, given the acute presentation without identified trigger and absence of angioedema.